Stock futures are little changed ahead of key inflation data: Live updates

Stock futures are little changed ahead of key inflation data: Live updates


Traders work on the floor of the New York Stock Exchange (NYSE) on December 02, 2025 in New York City.

Spencer Platt | Getty Images

Stock futures are little changed Thursday night as traders await inflation data that could further inform the Federal Reserve’s upcoming interest rate decision.

Futures tied to the Dow Jones Industrial Average added 3 points, or 0.01%. S&P futures and Nasdaq 100 futures were both slightly above the flatline.

In the previous session, the S&P 500 and Nasdaq Composite closed slightly higher, while the Dow Jones Industrial Average ended the day just below the flatline. The tech-heavy Nasdaq closed its eighth positive session in nine, buoyed by a 3.4% gain in Meta shares and a 2.1% gain in Nvidia.

Traders are keeping a close eye on a variety of economic data points, as the November payrolls report is scheduled to come out after the Fed’s Dec. 10 meeting.

Investors earlier digested a report from job placement firm Challenger, Gray & Christmas that showed job cuts in November moved ahead of 1 million for the year, with corporate restructuring, artificial intelligence and tariffs contributing to the losses. Thursday’s release of the latest weekly jobless claims numbers — which showed new applications for unemployment insurance at their lowest level since Sept. 2022 — did not appear to dent sentiment during the trading session.

Investors are hoping that signs of a softening labor market will influence the Fed to lower rates by a quarter percentage point at its next meeting. Traders are pricing in an 87% chance of a cut next Wednesday, far higher than just a couple weeks ago, according to the CME FedWatch tool.

“The data is mixed that we’re getting, and you’re seeing different signals. Inflation is still sticky where it is,” Sonali Basak, iCapital chief investment strategist, said Thursday on CNBC’s “Closing Bell.” “2026 is a wild card as it pertains to inflation. No one has that crystal ball. And you have that with the labor market that has generally held up ‘low hire-low fire.’ If that tips over, then you’re in a pretty sticky spot next year.”

The market will be able to sort through a fresh slate of economic releases on Friday. The Commerce Department will release delayed September data on consumer spending and incomes as well as the personal consumption expenditures index, also considered the Fed’s primary inflation gauge. The PCE report will be the first one since the record-setting U.S. government shutdown. The University of Michigan will also release its consumer survey for December on Friday.

Stocks are managing to eke out slight gains this week. The S&P 500 is up 0.1%, while the Nasdaq and 30-stock Dow have added nearly 0.6% and 0.3%, respectively.



Source

Fed’s Goolsbee calls for a hold on cuts as current rate of inflation is ‘not good enough’
World

Fed’s Goolsbee calls for a hold on cuts as current rate of inflation is ‘not good enough’

Austan Goolsbee, president and chief executive officer of the Federal Reserve Bank of Chicago, speaks during the National Association of Business Economics (NABE) economic policy conference in Washington, DC, US, on Tuesday, Feb. 24, 2026. Graeme Sloane | Bloomberg | Getty Images Chicago Federal Reserve President Austan Goolsbee said Tuesday that interest rate cuts aren’t […]

Read More
Classic ‘TACO’? Investors shrug off Trump’s latest tariff announcement
World

Classic ‘TACO’? Investors shrug off Trump’s latest tariff announcement

US President Donald Trump speaks during the Angel Families Remembrance Ceremony in the East Room of the White House in Washington, DC, on February 23, 2026. Saul Loeb | Afp | Getty Images U.S. President Donald Trump’s new blanket tariffs came into force on Tuesday — but investors appear to be shrugging the changes off, […]

Read More
Novo Nordisk to slash GLP-1 list prices by up to 50% in U.S. to cut costs for insured patients
World

Novo Nordisk to slash GLP-1 list prices by up to 50% in U.S. to cut costs for insured patients

The logo of pharmaceutical company Novo Nordisk is displayed in front of its offices in Bagsvaerd, Copenhagen, Denmark, Feb. 4, 2026. Tom Little | Reuters Novo Nordisk on Tuesday said it plans to slash the monthly list prices of its popular obesity and diabetes drugs in the U.S. by up to 50% starting in 2027, […]

Read More